Different clinical value of minimal residual disease after autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia
Open Access
- 1 March 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (5) , 1873-1874
- https://doi.org/10.1182/blood.v99.5.1873
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapyBlood, 2001
- Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease statusLeukemia, 2001
- A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemiaLeukemia, 2000
- Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host diseaseLeukemia, 2000
- Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia [letter]Blood, 1993